<?xml version='1.0' encoding='UTF-8'?><?xml-stylesheet href='static/style.xsl' type='text/xsl'?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-11-22T09:49:49Z</responseDate><request verb="GetRecord" identifier="oai:ecommons.cornell.edu:1813/31140" metadataPrefix="dim">https://ecommons.cornell.edu/server/oai/request</request><GetRecord><record><header><identifier>oai:ecommons.cornell.edu:1813/31140</identifier><datestamp>2026-05-14T13:57:22Z</datestamp><setSpec>com_1813_35</setSpec><setSpec>col_1813_47</setSpec></header><metadata><dim:dim xmlns:dim="http://www.dspace.org/xmlns/dspace/dim" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://www.dspace.org/xmlns/dspace/dim http://www.dspace.org/schema/dim.xsd">
   <dim:field mdschema="dc" element="contributor" qualifier="author" lang="en_US">Bardowell, Sabrina</dim:field>
   <dim:field mdschema="dc" element="contributor" qualifier="chair" lang="en_US">Parker, Robert Stanley</dim:field>
   <dim:field mdschema="dc" element="contributor" qualifier="committeeMember" lang="en_US">Cassano, Patricia Ann</dim:field>
   <dim:field mdschema="dc" element="contributor" qualifier="committeeMember" lang="en_US">Gu, Zhenglong</dim:field>
   <dim:field mdschema="dc" element="contributor" qualifier="committeeMember" lang="en_US">O'Brien, Kimberly O</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="accessioned">2013-01-31T19:44:28Z</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="available">2017-12-20T07:00:30Z</dim:field>
   <dim:field mdschema="dc" element="date" qualifier="issued" lang="en_US">2012-08-20</dim:field>
   <dim:field mdschema="dc" element="identifier" qualifier="uri">https://hdl.handle.net/1813/31140</dim:field>
   <dim:field mdschema="dc" element="identifier" qualifier="bibid">7959897</dim:field>
   <dim:field mdschema="dc" element="description" qualifier="abstract" lang="en_US">Vitamin E is a group of compounds that are considered to be the most important lipophilic antioxidants, however there is still much unknown about the biological actions of the various forms of vitamin E as well as the mechanisms that influence the concentration of vitamin E forms in tissues. Despite the common predominance of mainly [gamma]-tocopherol ([gamma]-TOH) in the diet, [alpha]-TOH is present in serum and tissues at levels 5-6 times that of [gamma]-TOH. The biological rational for this selectivity remains an enigma. The focus of this work was on the selective postabsorptive catabolism of non-[alpha]-TOH forms via the vitamin E-[omega]-oxidation pathway. Cytochrome P450 4F2 (CYP4F2) is the only known human enzyme shown to display TOH-[omega]-hydroxylase activity. In an effort to investigate the role of TOH-[omega]-hydroxylase activity in vitamin E metabolism and status, the functional murine ortholog of CYP4F2 was identified and the consequences of its deletion on vitamin E metabolism and status were determined. In vivo and in vitro studies revealed Cyp4f14 to be the major, but not the only, vitamin E-[omega]-hydroxylase in mice, and to have critical function in regulating body-wide vitamin E status. Disruption of Cyp4f14 expression resulted in hyper-accumulation of [gamma]-TOH in mice fed a soybean oil diet in which the major tocopherol was [gamma]-TOH. Supplementation of Cyp4f14-/- mice with high levels of [delta]- and [gamma]-TOH exacerbated the tissue enrichment of these forms of vitamin E. Through the use of  metabolic cage studies, previously unappreciated mechanisms of vitamin E elimination were discovered, which served to counterbalance the metabolic deficit observed in Cyp4f14-/- mice. Fecal elimination of unmetabolized TOHs was determined to be a high capacity mechanism to be minimize diet induced accumulation of TOHs, especially at high dietary levels. Additionally, novel [omega]-1 and [omega]-2 vitamin E hydroxylase activities were discovered and were found to quantitatively important vitamin E elimination mechanisms. Cyp4f14-/- mice also revealed the existence of other hepatic TOH-[omega]-hydroxylase enzyme(s). Therefore genetically modified mice, in which no CYP activity was present in the liver, were utilized in order to eliminate all hepatic vitamin E metabolism. Metabolic cage studies revealed the presence of vitamin E hydroxylase activity in non-hepatic tissues. Mouse and human small intestine mucosa were found to have TOH-[omega]-hydoxylase activity, representing at least one site of extra-hepatic vitamin E metabolism. Lastly, the use of cell culture studies demonstrated that two polymorphisms in CYP4F2 functionally alter TOH-[omega]-hydroxylase activity, which may play a role in vitamin E status in humans. Overall, the current works lends new insights into the physiological role of the TOH-[omega]oxidation pathway as well as reveals novel mechanisms of vitamin E metabolism in both mice and humans, which play an important role in the regulation of vitamin E status.</dim:field>
   <dim:field mdschema="dc" element="language" qualifier="iso" lang="en_US">en_US</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">vitamin E</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">cytochrome P450</dim:field>
   <dim:field mdschema="dc" element="subject" lang="en_US">metabolism</dim:field>
   <dim:field mdschema="dc" element="title" lang="en_US">The Role Of Vitamin E Hydroxylases In Vitamin E Metabolism And Status</dim:field>
   <dim:field mdschema="dc" element="type" lang="en_US">dissertation or thesis</dim:field>
   <dim:field mdschema="dc" element="format" qualifier="mimetype">application/pdf</dim:field>
   <dim:field mdschema="thesis" element="degree" qualifier="discipline">Nutrition</dim:field>
   <dim:field mdschema="thesis" element="degree" qualifier="grantor" lang="en_US">Cornell University</dim:field>
   <dim:field mdschema="thesis" element="degree" qualifier="level">Doctor of Philosophy</dim:field>
   <dim:field mdschema="thesis" element="degree" qualifier="name">Ph. D., Nutrition</dim:field>
   <dim:field mdschema="dspace" element="entity" qualifier="type">Publication</dim:field>
   <dim:field mdschema="cris" element="virtual" qualifier="collection" authority="https://cornell-ecommons.eks.prod.4science.cloud/handle/1813/47" confidence="600">Cornell Theses and Dissertations</dim:field>
   <dim:field mdschema="cris" element="virtual" qualifier="author" lang="en_US">Bardowell, Sabrina</dim:field>
   <dim:field mdschema="cris" element="virtualsource" qualifier="collection">5893a6ea-7af3-41d7-abc6-04bcd26ab5df</dim:field>
   <dim:field mdschema="others" element="access-status">open.access</dim:field>
   <dim:field mdschema="others" element="access-status">open.access</dim:field>
   <dim:field mdschema="cerif" element="openaire" authority="" confidence="-1">&lt;Publication xmlns="https://www.openaire.eu/cerif-profile/1.1/" id="2d7b6585-b5c8-47b3-a910-2476fba5c46b">
	&lt;Type xmlns="https://www.openaire.eu/cerif-profile/vocab/COAR_Publication_Types">http://purl.org/coar/resource_type/c_1843&lt;/Type>
	&lt;Language>en_US&lt;/Language>
   	&lt;Title>The Role Of Vitamin E Hydroxylases In Vitamin E Metabolism And Status&lt;/Title>
   	&lt;PublishedIn>
    	&lt;Publication>
      	&lt;/Publication>
   	&lt;/PublishedIn>
   	&lt;PublicationDate>2012-08-20&lt;/PublicationDate>
   	&lt;Authors>
      	&lt;Author>
        	&lt;DisplayName>Bardowell, Sabrina&lt;/DisplayName>
         	&lt;Affiliation>
         		&lt;OrgUnit>
         		&lt;/OrgUnit>
         	&lt;/Affiliation>
      	&lt;/Author>
	&lt;/Authors>
   	&lt;Editors>
	&lt;/Editors>
    &lt;Publishers>
        &lt;Publisher>
            &lt;OrgUnit />
        &lt;/Publisher>
    &lt;/Publishers>
    &lt;Keyword>vitamin E&lt;/Keyword>
    &lt;Keyword>cytochrome P450&lt;/Keyword>
    &lt;Keyword>metabolism&lt;/Keyword>
   	&lt;Abstract>Vitamin E is a group of compounds that are considered to be the most important lipophilic antioxidants, however there is still much unknown about the biological actions of the various forms of vitamin E as well as the mechanisms that influence the concentration of vitamin E forms in tissues. Despite the common predominance of mainly [gamma]-tocopherol ([gamma]-TOH) in the diet, [alpha]-TOH is present in serum and tissues at levels 5-6 times that of [gamma]-TOH. The biological rational for this selectivity remains an enigma. The focus of this work was on the selective postabsorptive catabolism of non-[alpha]-TOH forms via the vitamin E-[omega]-oxidation pathway. Cytochrome P450 4F2 (CYP4F2) is the only known human enzyme shown to display TOH-[omega]-hydroxylase activity. In an effort to investigate the role of TOH-[omega]-hydroxylase activity in vitamin E metabolism and status, the functional murine ortholog of CYP4F2 was identified and the consequences of its deletion on vitamin E metabolism and status were determined. In vivo and in vitro studies revealed Cyp4f14 to be the major, but not the only, vitamin E-[omega]-hydroxylase in mice, and to have critical function in regulating body-wide vitamin E status. Disruption of Cyp4f14 expression resulted in hyper-accumulation of [gamma]-TOH in mice fed a soybean oil diet in which the major tocopherol was [gamma]-TOH. Supplementation of Cyp4f14-/- mice with high levels of [delta]- and [gamma]-TOH exacerbated the tissue enrichment of these forms of vitamin E. Through the use of  metabolic cage studies, previously unappreciated mechanisms of vitamin E elimination were discovered, which served to counterbalance the metabolic deficit observed in Cyp4f14-/- mice. Fecal elimination of unmetabolized TOHs was determined to be a high capacity mechanism to be minimize diet induced accumulation of TOHs, especially at high dietary levels. Additionally, novel [omega]-1 and [omega]-2 vitamin E hydroxylase activities were discovered and were found to quantitatively important vitamin E elimination mechanisms. Cyp4f14-/- mice also revealed the existence of other hepatic TOH-[omega]-hydroxylase enzyme(s). Therefore genetically modified mice, in which no CYP activity was present in the liver, were utilized in order to eliminate all hepatic vitamin E metabolism. Metabolic cage studies revealed the presence of vitamin E hydroxylase activity in non-hepatic tissues. Mouse and human small intestine mucosa were found to have TOH-[omega]-hydoxylase activity, representing at least one site of extra-hepatic vitamin E metabolism. Lastly, the use of cell culture studies demonstrated that two polymorphisms in CYP4F2 functionally alter TOH-[omega]-hydroxylase activity, which may play a role in vitamin E status in humans. Overall, the current works lends new insights into the physiological role of the TOH-[omega]oxidation pathway as well as reveals novel mechanisms of vitamin E metabolism in both mice and humans, which play an important role in the regulation of vitamin E status.&lt;/Abstract>
	&lt;Access xmlns="http://purl.org/coar/access_right" 
    >
    &lt;/Access>
&lt;/Publication>
</dim:field>
</dim:dim>
</metadata></record></GetRecord></OAI-PMH>